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Importance 
Surra, caused by Trypanosoma evansi, is one of the most important diseases of 
animals in tropical and semitropical regions. While surra is particularly serious in 
equids and camels, infections and clinical cases have been reported in most 
domesticated mammals and some wild species. T. evansi is transmitted mechanically 
by various tabanids and other flies, and it can readily become endemic when 
introduced into a new area. The morbidity and mortality rates in a population with no 
immunity can be high. In the early 1900s, an outbreak in Mauritius killed almost all 
of the Equidae on the island. More recently, severe outbreaks have been reported in 
the Philippines, Indonesia and Vietnam. In addition to illness and deaths, surra causes 
economic losses from decreased productivity in working animals, reduced weight 
gain, decreased milk yield, reproductive losses and the cost of treatment. 
Etiology 
Surra is caused by the protozoal parasite Trypanosoma evansi. This organism 
belongs to the subgenus Trypanozoon and the Salivarian section of the genus 
Trypanosoma. Two genetic types of T. evansi, type A and type B, have been 
recognized. Most isolates worldwide belong to type A. Type B, which is not 
recognized by some diagnostic tests, has only been detected in parts of Africa as of 
2015. Whether T. evansi should be considered a distinct species, separate from T. 
brucei, is controversial. 
Species Affected 
The principal hosts and reservoirs for T. evansi are reported to differ between 
regions; however, camels, equids, water buffalo and cattle are generally considered to 
be the major hosts among domesticated animals. Equids, Bactrian camels (Camelus 
bactrianus) and dromedaries (Camelus dromedarius) are highly susceptible to 
disease. Infections are usually mild or asymptomatic in cattle, water buffalo and 
related species in the Bovinae (the genera Bos, Bubalus, Syncerus, and Poephagus) in 
Africa or Latin America, but cattle and water buffalo regularly become ill in Asia. 
Many other mammals and marsupials are also susceptible to varying degrees; clinical 
cases have been reported in South American camelids, deer, sheep, goats, pigs, dogs, 
cats, tigers (Panthera onca), jaguars (Panthera onca), elephants, Sumatran 
rhinoceroses (Dicerorhinus sumatrensis sumatrensis), Himalayan black bears 
(Selenarctos thibetanus), coati (Nasua nasua), and experimentally infected wallabies 
(e.g., Macropus agilis and Thylogale brunii) and bandicoot rats (Bandicota 
bengalensis).  
Infections have been documented in many wild mammals (e.g., various cervids, 
other large ungulates, wild pigs, lagomorphs, felids, canids, primates, small 
mammals) and marsupials, with or without disease, and some of these animals may 
help maintain T. evansi. In particular, vampire bats (Desmodus rotundus) are 
considered to be reservoirs as well as vectors in South America. Various small 
mammals, including capybara (Hydrochaeris hydrochaeris), have also been proposed 
as possible maintenance hosts. Some birds (e.g., young pigeons, chicks) can be 
infected experimentally, but their susceptibility in nature is uncertain.  
Zoonotic potential 
While T. evansi is not currently considered to be zoonotic, a few cases have been 
reported in humans. It is uncertain whether all of these infections occurred in people 
who are unusually susceptible or the disease is underdiagnosed. 
Geographic Distribution 
Surra is enzootic in Africa, the Middle East, many parts of Asia, and Central and 
South America. It also occurs in the Canary Islands of Spain, although control 
programs appear to have limited the organism to one small region.  
Transmission 
T. evansi does not require a biological vector. This organism, which can be found 
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in blood and tissues, is transmitted mechanically by biting 
insects. Members of the deerfly and horsefly family, 
Tabanidae (e.g., the genera Tabanus, Atylotus, Chrysops, 
Lyperosia, and Haematopota) and flies in the genus 
Stomoxys are thought to be the most important vectors. 
Transmission by other biting insects (e.g., Hippobosca spp., 
mosquitoes in the family Culicidae, and midges in the 
family Ceratopogonidae) has been reported experimentally 
or suspected in the field, and might contribute to local 
spread. Sucking flies, such as Musca spp., may spread T. 
evansi when they visit contaminated wounds. Other 
organisms proposed as potential vectors include ticks and 
leeches, such as buffalo leeches in Asia.  
Additional means of transmission include iatrogenic 
spread on contaminated needles or surgical instruments, and 
the ingestion of infected tissues by carnivores. Vampire 
bats can both maintain T. evansi and act as mechanical 
vectors in South and Central America. Transplacental 
transmission has been demonstrated in ruminants and 
donkeys, and transmission in milk and colostrum was 
reported in experimentally infected sheep. Trypanosomes 
cannot survive for long periods outside the host, and 
disappear relatively quickly from the carcass after death. In 
one recent study, organisms were detected as long as 13-15 
hours in the heart blood of mice, although their viability 
had decreased to ≤ 5% by this time. 
Disinfection 
There is limited need for disinfectants, due to the 
fragility of trypanosomes in the environment, and no 
studies appear to have examined disinfectant susceptibility 
specifically for T. evansi. The closely related organism T. 
brucei can be inactivated by various agents including 
0.05% sodium hypochlorite, 70% ethanol, 2% TriGene™, 
0.1% hand soap, 2% formaldehyde and 0.05% 
glutaraldehyde. The temperature reported to kill 100% of 
trypomastigotes is 50°C. 
Incubation Period 
In the Equidae, the incubation period ranges from 
approximately one week to 2 months, with most cases 
appearing in 1-4 weeks.  
Clinical Signs 
Surra can be an acute, subacute or chronic disease, with 
the severity of the clinical signs differing between 
individual animals, as well as between species. Some 
animals die rapidly, especially among highly susceptible 
species such as horses and camels; in other cases, clinical 
signs may persist for months or years. Such chronic 
illnesses can occur in less susceptible species, but they may 
also be prevalent among equids and camels in endemic 
regions. Animals can also carry T. evansi subclinically. 
Common clinical signs include fever (which can be 
intermittent in chronic cases), weight loss or wasting, 
lethargy, signs of anemia and enlargement of the lymph 
nodes. There may also be dependent edema, jaundice, 
petechial hemorrhages of the mucous membranes and 
abortions or stillbirths. Neurological signs have been 
documented in a number of species, especially in the late 
stages, and ataxia, with gradually progressive paresis of the 
hindquarters accompanied by muscle atrophy, is reported to 
be a common sign among horses in South America. Horses 
may have episodes of urticaria, and this sign was also 
reported in an outbreak among pigs. Testicular lesions in 
camels and experimentally infected goats suggest that, in 
some species, male fertility might also be impaired.  
Additional signs documented in individual species 
include facial and laryngeal edema and ocular signs (e.g., 
conjunctivitis, keratitis, corneal opacity, anterior uveitis 
and/or hemorrhages) in dogs; diarrhea and conjunctivitis in 
some water buffalo; decreased milk production in dairy 
cattle; facial edema in Asian elephants; nasal hemorrhages 
in rhinoceroses; respiratory signs (dyspnea, coughing), 
diarrhea, ocular signs or arthritis in some experimentally 
infected goats; and diarrhea, vomiting, ocular signs, facial 
and limb edema, and external and internal abscesses in 
some experimentally infected cats. In addition, T. evansi 
causes leukopenia, which may result in immunosuppression 
and might decrease vaccine responses or exacerbate other 
conditions.  
Post Mortem Lesions 
The gross lesions tend to be nonspecific, and may 
include wasting or emaciation of the carcass, subcutaneous 
edema, signs of anemia, enlargement of the spleen, liver 
and lymph nodes, and petechiae on some internal organs. 
Muscle atrophy may be noted, particularly in the 
hindquarters. Icterus and nephritis may also be present. 
Fluid accumulation in other body cavities (e.g., ascites, 
hydrothorax) is sometimes seen. Cardiac lesions including 
hydropericardium, pericarditis and evidence of 
cardiomyopathy or myocarditis occur in some animals. The 
lungs may also be affected in some species; respiratory 
lesions (congestion, consolidation, edema, emphysema, 
hemorrhages and/or pneumonia) were reported in some T. 
evansi-infected cattle and water buffalo and some 
experimentally infected bandicoots, rats, mice and coatis.  
In some horses with neurological signs, the cerebral 
hemispheres may be swollen and the gyri flattened. There 
may be severe edema and malacia, with the white matter 
becoming yellow, gelatinous and friable. Subpial 
hemorrhages may also be present. 
Diagnostic Tests 
A presumptive diagnosis may be possible if 
organisms consistent with T. evansi are detected in the 
blood, lymph nodes, tissues (e.g., at necropsy) or edema 
fluid by direct examination, and other trypanosomes do 
not exist in the area. While T. evansi differs in 
morphology from some other trypanosomes, it cannot be 
distinguished from certain species such as T. equiperdum. 
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In addition, atypical forms have been observed in some 
outbreaks (e.g., organisms that resembled T. vivax during 
the 2008 surra outbreak in Spain). Blood should be 
collected from live animals during a febrile period. The 
organism may be difficult to find, especially in mild or 
subclinical cases, and parasitemia is often intermittent in 
chronically infected animals. Repeated sampling may be 
necessary.  
Microscopy specimens used to look for trypanosomes 
include wet blood films, used to detect the motile 
organisms, and thick or thin stained blood smears. Thick 
films have the advantage of being able to detect parasites 
in low numbers; however, the morphology of the parasite 
is difficult to determine. Detection can be improved with 
parasite concentration techniques including mini anion-
exchange chromatography, hemolysis methods that use 
sodium dodecyl sulphate (SDS) to destroy the erythrocytes 
(i.e., wet blood film clarification or hemolysis 
centrifugation), hematocrit centrifugation (Woo method) or 
the dark-ground/phase-contrast buffy coat technique 
(Murray method). The latter two methods rely on the 
concentration of trypanosomes near the buffy coat after 
centrifugation.  
Polymerase chain reaction (PCR) assays are used in 
some laboratories. They can identify the organism to the 
level of the subgenus Trypanozoon, but cannot distinguish 
it from T. equiperdum. Recombinant DNA probes may also 
be employed, but are not in routine use.  
In some horses with neurological signs, 
immunohistochemical staining could detect parasites in the 
brain, even when they were not visible in hematoxylin and 
eosin stained sections. This technique has also been used to 
detect T. evansi in the brains of cattle, hog deer and buffalo. 
Other antigen detection tests have also been published; 
however, the most recent World Organization for Animal 
Health (OIE) Manual of Diagnostic Tests and Vaccines did 
not currently consider any method to be sufficiently 
developed for routine diagnosis using blood or serum.  
Serological tests include ELISAs and card 
agglutination tests (CATT). The CATT detects IgM and is 
particularly useful early in the course of the disease. The 
trypanolysis test may be employed to confirm positive 
results, and immunofluorescent assays can be used with 
small numbers of samples. All serological tests may not 
have been validated or standardized for a host species, and 
cross-reactions can occur with other trypanosomes.  
Some serological and molecular tests, including PCR, 
may not detect the type B T. evansi variants reported from 
parts of Africa. Assays that can recognize type B isolates 
and/or distinguish types A and B include mobile genetic 
element PCR (MGE-PCR) and loop-mediated isothermal 
amplification (LAMP). 
Animal inoculation studies in rats or mice may be used, 
if necessary, to detect low levels of parasites, such as when 
importing an animal into a surra-free regions. They are not 
generally recommended unless the need is critical. 
Treatment 
Surra can be treated with antiparasitic (trypanocidal) 
drugs. The efficacy and toxicity of a particular drug may 
differ between species. Depending on the drug dose and 
other factors, treatment may be clinically curative without 
completely eliminating the parasite, and relapses are 
possible. Drug resistance also occurs. Cases with 
neurological signs are very difficult to treat, although some 
newer drugs may cross the blood-brain barrier to some 
extent. 
Treatment may or may not be permitted in countries 
where T. evansi is not endemic. 
Control 
Disease reporting 
A quick response is vital for containing outbreaks in 
surra-free regions. Veterinarians who encounter or suspect a 
T. evansi infection should follow their national and/or local 
guidelines for disease reporting. In the U.S., state or federal 
veterinary authorities should be informed immediately. 
Prevention 
T. evansi is excluded from uninfected areas by 
quarantines and testing. This organism has often become 
endemic after its introduction into a new area, due to the 
large number of potential hosts and its ability to be 
transmitted mechanically by numerous biting insects. 
Nevertheless, eradication was successful in a few cases 
when the outbreak was recognized early. In some instances, 
such outbreaks were controlled by quarantines, movement 
controls and the slaughter of infected animals. In 2008, an 
outbreak among camels and equids on an isolated farm in 
Spain was eradicated by treating the infected camels, with 
isolation and monitoring in a closed stable for 6 years. Two 
equids were euthanized 4 months after treatment; however, 
treatment appeared to be effective in the camels. An 
outbreak in France in 2006 was also eradicated by isolating 
and treating camels but euthanizing seropositive sheep in 
the area. 
In endemic areas, it is difficult to control the biting 
flies that transmit T. evansi; however, some animals may be 
protected with insecticides/ repellents, traps, insect 
screens/netting in stables, and/or other controls. In one 
recent outbreak, most cases occurred among horses kept in 
open paddocks, while horses in nearby fly-proof stables 
were spared. Flies are most infective soon after feeding on 
an infected host (e.g., in the first half hour), and the highest 
probability of transmission is to nearby hosts. Because 
tabanids are persistent feeders and do not usually leave one 
animal to bite another more than 50 meters away, it is also 
considered advisable to separate highly susceptible animals, 
such as horses, from herds of cattle, water buffalo or other 
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animals that may be subclinical hosts. In South America, 
animals should also be protected from vampire bats.  
Antiparasitic drugs are used routinely to protect 
susceptible animals in some endemic regions. Carnivores 
and omnivores should not be allowed to eat the carcasses of 
infected animals. No vaccines are available. 
Morbidity and Mortality 
The severity of the clinical signs can vary with the 
strain of T. evansi and with host factors including previous 
exposures, stress, concurrent infections and general health. 
Horses and camels are generally considered to be the most 
susceptible species, and often develop severe illness, with 
high case fatality rates, even in endemic regions. Donkeys 
and mules are reported to have less severe signs than 
horses. In camels, surra is most common soon after 
weaning, but can occur in all ages. Severe outbreaks are 
especially likely when T. evansi is introduced into disease–
free areas or susceptible animals are moved into endemic 
regions. Morbidity rates of 50% or greater, with comparable 
mortality, can be seen in some herds. Chronically or 
subclinically infected animals may relapse with parasitemia 
under conditions of stress. 
Infections are often milder in other species of 
mammals; nevertheless, severe cases and deaths have been 
documented in many species including water buffalo, cattle, 
other domesticated animals and captive wild animals. Why 
surra is much more likely to become clinical among cattle 
and water buffalo in Asia than Africa or Latin America is 
uncertain; however, mortality rates ranging from 10% to 
>90% have sometimes been reported among bovids in Asia, 
especially where T. evansi was newly introduced. Among 
carnivores, clinical cases have been reported more often in 
dogs than cats, and can be severe. Some studies suggest that 
infections might be relatively common in this species. 
Approximately 2% of dogs tested by microscopic 
examination had trypanosomes in one endemic region in 
India, and 29% of dogs were seropositive in a survey in 
Brazil. Deaths are especially likely in untreated stray dogs, 
but can also occur despite treatment.  
Public Health 
Humans possess innate resistance against many species 
of trypanosomes, including T. evansi, due to the 
trypanolytic activity of the serum protein apolipoprotein L-
I. Nevertheless, there have been a small number of human 
infections with atypical trypanosomes, including a few 
infections caused by T. evansi. Whether illnesses caused by 
this organism are underestimated or occur very rarely and 
under unusual circumstances is currently unclear. 
One T. evansi infection was reported in 1977, in a 
laboratory worker exposed to contaminated blood. The 
symptoms included insomnia, memory loss, tachycardia 
and an enlarged liver, spleen, and lymph nodes, and 
resolved after treatment with an antitrypanosomal drug. 
While the parasite was identified only by morphology 
(which is not definitive), the diagnosis appears likely in this 
case. A definitive diagnosis was established in two 
naturally-occurring cases. One occurred in 2005, in a 45-
year-old Indian farmer who had a genetic defect in 
apolipoprotein L1. His symptoms included intermittent 
fever, chills, sweats and neurological signs. The diagnosis 
was established by PCR and antiparasitic treatment was 
successful. The other case occurred in Sri Lanka in 1999, in 
a patient who had a headache and intermittent fever. While 
this case was not published in the scientific literature, a 
recent review article reported that the identity of the 
parasite had been confirmed by PCR. Four additional 
suspected cases, diagnosed only by parasite morphology, 
were reported from India. They included one person who 
died 2 days after admission to a hospital. Another suspected 
case (2010) was a cattle farmer in Egypt who had recurrent 
episodes of fever. He was reported to have been 
hospitalized and “successfully treated.” 
In 2005, a study conducted in the village of the farmer 
with the apolipoprotein L1 defect did not detect 
trypanosomes in the blood of any other humans, although 
some people were seropositive. The serological test used 
has not been validated in humans. In a study from Egypt, 
published in 2013, there was no virological evidence of T. 
evansi infection in camel owners, using either PCR or 
microscopic examination of blood smears, although 10-
46% of their camels had evidence of infection. A new 
organization, the Network on Atypical Human Infection by 
Animal Trypanosomes (NAHIAT) was established in 2011, 
and is coordinated by the Institute of Research for 
Development (IRD) and the Center for International 
Collaboration on Agricultural Research for Development 
(CIRAD). Its purpose is to coordinate information and 
research about various atypical trypanosomes, including T. 
evansi, in humans. 
Internet Resources 
Center for International Collaboration on Agricultural 
Research for Development (CIRAD), France 
http://www.cirad.fr/en 
Institute of Research for Development (Institut de 
Recherche pour le Développement) France 
http://www.ird.lk/ 
The Merck Veterinary Manual  
http://www.merckvetmanual.com/mvm/index.html 
World Organization for Animal Health (OIE) 
http://www.oie.int  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
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OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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